No Data
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
Morgan Stanley Maintains 10x Genomics(TXG.US) With Buy Rating, Maintains Target Price $30
A Quick Look at Today's Ratings for 10x Genomics(TXG.US), With a Forecast Between $14 to $30
TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative
These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results
10x Genomics Is Maintained at Neutral by JP Morgan
La Tortuga : Why. Tutes are buying. This is a long steady climb. I like seeing green in my portfolio.
123456FEDCBA La Tortuga : Where is the green? Only see huge red for the longest time.
bowzerWoo_ OP 123456FEDCBA : yes I bought 4 at 28$ I sold on that last big drop to under 15$....lameeee . no growth just drop drop drop. all it's been doing the last year is steadily dropping. no recovery!!! sell!!
104766059 : I have 30 I. My portfolio. Who is tutes?